Amendment of the Misuse of Drugs Regulations 20012
1
The following amendments are made to the Misuse of Drugs Regulations 20012.
2
In paragraph 1(a) of Schedule 1 (which specifies controlled drugs subject to the requirements of regulations 14, 15, 16, 18, 19, 20, 23, 26 and 27)—
a
after “Bromazolam (8-bromo-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine)” insert “Brorphine”
;
b
after “Bufotenine” insert “Butonitazene”
;
c
after “Clonazolam (6-(2-Chlorophenyl)-1-methyl-8-nitro-4H-[1,2,4]triazolo[4,3-a][1,4] benzodiazepine)” insert “Clonitazene”
;
d
after “Concentrate of poppy-straw” insert “Cumyl-PeGaClone”
;
e
after “3-Dimethylheptyl-11-hydroxyhexahydrocannabinol” insert—
Diphenidine
Ephenidine
Ethyleneoxynitazene
f
after “Etizolam” insert—
Etodesnitazene (etazene)
Etonitazene
g
after “Flubromazolam (8-Bromo-6-(2-fluorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4] benzodiazepine)” insert “Flunitazene”
;
h
after “Isopropylphenidate (IPP or IPPD)” insert “Isotonitazene”
;
i
after “Methcathinone” insert “Methoxyphenidine”
;
j
after “Metizolam (4-(2-Chlorophenyl)-2-ethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4] diazepine)” insert—
Metodesnitazene (metazene)
Metonitazene
k
after “Propylphenidate” insert “Protonitazene”
;
l
after “1-Cyclohexyl-4-(1,2-diphenylethyl)piperazine (MT-45)” insert—
N-Desethyl etonitazene
N-Desethylisotonitazene
N-Desethyl protonitazene
m
after “4-Methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine (4,4’-DMAR)” insert—
N-Piperidinyl-etonitazene (etonitazepipne)
N-Pyrrolidino-etonitazene (etoniazepyne)
N-Pyrrolidino protonitazene
3
In paragraph 1 of Schedule 2 (which specifies controlled drugs subject to the requirements of regulations 14, 15, 16, 16A, 18, 19, 20, 21, 23, 26 and 27) omit “Clonitazene” and “Etonitazene”.
4
In paragraph 1 of Part 1 of Schedule 4 (which specifies controlled drugs subject to the requirements of regulations 22, 23, 26 and 27) after “Pyrovalerone” insert “Remimazolam”
.